Anzeige
Mehr »
Mittwoch, 13.08.2025 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
244 Leser
Artikel bewerten:
(1)

Corza Medical Inc.: Corza Medical Launches Biomedical Textiles Innovation Lab to Accelerate OEM Product Development

TAUNTON, U.K., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Corza Medical, a leading global manufacturer of surgical technologies and medical device components announced today the launch of its Biomedical Textiles Innovation Lab, a state-of-the-art facility designed to help OEM partners rapidly prototype, test, and optimize textile-based medical materials.

Located in Taunton, UK, the Innovation Lab provides Corza Medical's partners with a collaborative, hands-on environment where concepts can be transformed into validated prototypes within days versus weeks. Equipped with advanced analytical testing capabilities and supported by a highly experienced team of textile development specialists, the lab marks a significant advancement in reducing development cycles and accelerating time to market.

"The Innovation Lab represents our commitment to OEM partners who demand both speed, precision, and quality," said James Getty, Senior Vice President and General Manager of Biomedical Textiles at Corza Medical. "By bringing prototyping, testing, and engineering expertise together in one place, we're enabling our customers to move from concept to commercialization faster than ever before."

The facility supports a wide range of textile-based medical components, using high-performance absorbable and non-absorbable materials including Nylon, Silk, Polypropylene, Polyester, and Ultra-High-Molecular-Weight Polyethylene (UHMWPE). From advanced constructs to simple suture assemblies, the lab is equipped to meet a variety of OEM needs. Corza Medical delivers one of the most comprehensive material science portfolios in the industry, enabling advanced solutions in medical attachment, suturing, and connectivity.

Key capabilities of the Innovation Lab include:

  • Rapid Prototyping of textile structures, including complex configurations such as loops, splices, bifurcations, embroidery, and round-flat-round transitions
  • Suture Assembly Services including knot tying, cut-to-length, stitching, sewing, and packaging for device-ready components
  • Prototype-to-Scale Support to transition early-stage designs into commercially scalable solutions
  • In-House Testing Services including tensile strength, elongation, surface imaging, thermal analysis, and moisture response
  • Custom Engineering Collaboration to troubleshoot and refine device designs in real time
  • Confidential, Commitment-Free Engagements for early-stage exploration, feasibility validation, or competitive benchmarking

Each Innovation Lab engagement is fully customizable and results in a verified prototype for validation, supporting test data, and recommendations for next steps.

"This isn't just a lab. It's an accelerator for innovation," said Tariq Abalis, Head of Global Commercial of Biomedical Textiles at Corza Medical. "Whether our partners are optimizing an existing product or exploring a new concept, we're here to help them move faster with more confidence."

The Corza Medical Biomedical Textiles Innovation Lab is now accepting inquiries and scheduling lab collaborations.

To learn more or schedule a session, visit:https://corza.com/products/biomedical-textiles/?utm_source=press+release&utm_medium=social&utm_campaign=innovation+lab+launch

Media Contact:
Suzanne Hatcher
Global Communications
media@corza.com

Customer Contact:
Amy Jeary
Product Marketing Manager, Biomedical Textiles, Corza Medical
amy.jeary@corza.com

About Corza Medical
Corza Medical is a leading global medical technology company that specializes in innovative surgical solutions and technologies. With a global team of approximately 3,000 employees supporting clinicians, distributor partners and medical device companies worldwide, Corza provides healthcare professionals with a platform of surgical technologies featuring many industry-leading brands, including Quill® barbed sutures, Sharpoint® Plus and Look surgical sutures, Katena® reusable and Blink single-use ophthalmic instruments, Barron corneal transplant devices, Sharpoint® microsurgical knives and the TachoSil® fibrin sealant patch. For more information, please visit www.corza.com.


© 2025 GlobeNewswire (Europe)
Tech-Aktien mit Crash-Tendenzen
Künstliche Intelligenz, Magnificent Seven, Tech-Euphorie – seit Monaten scheint an der Börse nur eine Richtung zu existieren: nach oben. Doch hinter den Rekordkursen lauert eine gefährliche Wahrheit. Die Bewertungen vieler Tech-Schwergewichte haben historische Extremniveaus erreicht. Shiller-KGV bei 39, Buffett-Indikator auf Allzeithoch – schon in der Dotcom-Ära war der Markt kaum teurer.

Hinzu kommen euphorische Anlegerstimmung, IPO-Hypes ohne Substanz, kreditfinanzierte Wertpapierkäufe in Rekordhöhe und charttechnische Warnsignale, die Erinnerungen an 2000 und 2021 wecken. Gleichzeitig drücken geopolitische Risiken, Trumps aggressive Zollpolitik und saisonale Börsenschwäche auf die Perspektiven.

Die Gefahr: Aus der schleichenden Korrektur könnte ein rasanter Crash werden – und der könnte vor allem überbewertete KI- und Chipwerte hart treffen.

In unserem kostenlosen Spezial-Report zeigen wir Ihnen, welche Tech-Aktien am stärksten gefährdet sind und wie Sie Ihr Depot vor dem Platzen der Blase schützen könnten.

Holen Sie sich den neuesten Report!

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.